HeartBeam completes $16.5M IPO; net proceeds $14.9M for ECG product development

HeartBeam, Inc.

IPO of 2.75M units at $6/unit; each unit includes one share and one warrant exercisable at $6 for 5 years.
Gross proceeds $16.5M, net proceeds $14.9M after underwriting discounts and offering expenses.
Common stock and warrants trade on Nasdaq under symbols BEAT and BEATW.
Proceeds to fund FDA 510(k) clearance and commercial launch of ER and telehealth products.
Granted 87k options to CBO John Hunt and 44k options to director George de Urioste at $4.25 strike, vesting over 48 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.